JG Earnings

JG reported its earnings on 2026-03-12, showcasing a revenue of 15.04M against an estimate of , resulting in a 0% surprise. The EPS was 0.09, surpassing the expected 0 by 0%. The stock experienced a 0.43% price change on the earnings day and a 1.36% change over the next five days, reflecting market reactions to the results.

Following JG's earnings announcement on 2026-03-12, the stock price moved by 0.43% on the day of the release. Over the subsequent five days, it saw a 1.36% change. Historically, JG's stock price tends to shift by an average of 3.12% in the 10 days leading up to earnings and 3.54% in the 10 days following, providing insight into potential market.

For 2025/Q3, analysts estimate JG's annual revenue to reach 81.33M, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between JG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, JG's stock price typically moves by 3.12% in the 10 days before its earnings and 3.54% in the 10 days after. For the upcoming 2025/Q3 earnings, analysts expect an EPS of and revenue of 81.33M.

The earnings call reveals a mix of positive and negative elements. The company reported growth in revenue, income from operations, and adjusted EBITDA, indicating strong financial performance. The share repurchase program and strategic divestitures are positive for shareholder returns. However, the rising expenses and decreased inpatient cases pose challenges. The Q&A session highlighted some uncertainties, but overall, the positive financial metrics and shareholder-focused actions suggest a positive stock price movement.